Research

Study: Ibuprofen Safe for Infants Under 6 Months

Posted on Jul 25, 2018 in Children's Services, Research, Sutter Medical Center, Sacramento, Uncategorized

SACRAMENTO, Calif. – Ibuprofen is as safe for children under 6 months old as it is for those over that age, according to a recently published study on PLOS ONE by Dr. Paul Walsh, the medical director of Sutter Medical Center, Sacramento’s Pediatric Emergency Department.

Dr. Paul Walsh cares for a child in the Pediatric Emergency Department at Sutter Medical Center, Sacramento.

The U.S. Food and Drug Administration does not allow ibuprofen to be sold over-the-counter for parents to treat their sick children under the age of 6 months.  This has led to some pediatricians and family physicians to avoid ibuprofen in these infants. While there is significant information on ibuprofen’s safety for children over 6 months old, there was much less research on its use for infants under 6 months. Some community physicians and most hospital-based pediatric emergency departments as well as neonatal and pediatric intensive care units traditionally have used ibuprofen in these younger infants, said Dr. Walsh, the principal investigator of the study.

“While fever of itself is unlikely to be harmful, it can lead to fussiness and feeding refusal. This can lead to dehydration and an ill appearance,” Dr. Walsh said. “In this scenario, if acetaminophen alone isn’t bringing down the fever, an appropriate dose of Ibuprofen should be prescribed to reduce the fever, allow re-establishment of feeding and, in some cases, prevent unnecessary lab testing.” Read More

PAMF Research Institute’s Dr. Harold Luft Receives 2018 Centennial Medal from Harvard University

Posted on May 30, 2018 in Organizational News, Quality, Research, We're Awesome

Dr. Harold Luft, Ph.D., director, PAMF Research Institute

PALO ALTO, Calif.- Harold S. Luft, Ph.D., director of Sutter Health’s Palo Alto Medical Foundation Research Institute (PAMFRI), has been awarded the Centennial Medal from Harvard University’s Graduate School of Arts and Sciences, the school’s highest honor recognizing outstanding alumni whose contributions to knowledge, to their disciplines, to their colleagues, and to society have made a fundamental and lasting impact.

Dr. “Hal” Luft, who is also a senior scientist at PAMF’s Research Institute and the Caldwell B. Esselstyn Professor Emeritus of Health Policy and Health Economics at the Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco, received the honor for his influential work as a health care economist.

Dr. Luft was presented with the award on May 23 at a ceremony at the Graduate School of Arts and Sciences (GSAS) in Cambridge, Mass. He earned his bachelor’s, master’s and doctoral degrees in Harvard’s Department of Economics, completing his Ph.D. thesis in 1973 on the impact of poverty on health, and health on poverty, in America.

“Harold Luft’s dedication to advancing interdisciplinary, empirical research has improved health care for the benefit of millions of Americans,” said Emma Dench, GSAS interim dean. “We are proud to award him the 2018 Centennial Medal.”

Read More

PAMF Pulmonologist Performs First Robotic Bronchoscopy on a Patient in the U.S.

Posted on Apr 30, 2018 in Cancer, Innovation, Quality, Research, We're Awesome

New Procedure Advances Lung Cancer Diagnosis  and Treatment
                          

Ganesh Krishna, M.D.

Mountain View, Calif. – Ganesh Krishna, M.D., director of interventional pulmonology at PAMF, part of the not-for-profit Sutter Health network, successfully performed an innovative robotic bronchoscopy procedure to view the inside of the lungs and obtain a tissue sample from a patient with an abnormal CT scan of the chest.

This procedure, the first of its kind performed in the United States, took place on March 30 at El Camino Hospital, as part of a clinical trial of Auris Health’s Monarch Platform.

“Since the robotic bronchoscope has the ability to travel deeper into the lung and precisely guide a biopsy instrument to even the most difficult nodules, the technology offers the potential to diagnose lung cancer at an earlier stage,” said Dr. Krishna, who is also medical director of the Interventional Pulmonology Program at El Camino Hospital and fellowship director of the Interventional Pulmonary Fellowship Program in collaboration with University of California, San Francisco (UCSF).

Read More

Cord Blood Stem Cell Study Shows Promise for Autism

Posted on Feb 7, 2018 in Quality, Research, Uncategorized

SACRAMENTO, Calif. – A first-of-its-kind double-blinded, crossover study of children with autism who were treated with their own cord blood showed the treatment to be safe and suggests improvement in socialization.

Michael Chez, M.D., of Sutter Neuroscience Institute.

The study, which was published Feb. 6 in the medical journal Stem Cells Translational Medicine, involved 30 children and was conducted by Michael Chez, M.D., the primary investigator who designed the study that was carried out through the Sutter Neuroscience Institute of Sacramento and the Sutter Institute for Medical Research, with research grant funding by Cord Blood Registry® (CBR®). It was the first randomized, double-blinded, placebo-controlled trial performed in the United States to assess the feasibility of treating autistic children by using their own newborn cord blood harvested from their banked umbilical cord. The study can be viewed here.

Read More

Sutter Health Receives $3.2 Million Grant to Evaluate Type 2 Diabetes Prevention

Posted on Jan 19, 2018 in Quality, Research

Investment will help enhance and expand research efforts

 

PALO ALTO, Calif.—Sutter Health’s Palo Alto Medical Foundation Research Institute has secured funding from the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health to conduct a five-year study, evaluating the not-for-profit healthcare network’s experience with implementing Group Lifestyle Balance (GLB)™—a  group-based diabetes prevention program that has gained national attention for its success. Read More

Palo Alto Medical Foundation and Plusoptix Collaborate to Improve Vision Screening for Kids

Posted on Jan 10, 2018 in Quality, Research, Transformation

Easy to use, kids-friendly vision screening devices can help reduce the risk of lazy eye by more than 50 percent through comprehensive vision screening.1

 PALO ALTO, Calif.—Palo Alto Medical Foundation, an affiliate of Sutter Health , a leading not-for-profit health care system in Northern California, and Plusoptix, a world leader in instrument based vision screening, today announced they are working together to help improve routine vision screening for children in pediatric and family medicine clinics. More than 30 clinics at the Palo Alto Medical Foundation (PAMF) are utilizing vision screeners from Plusoptix as a way to ensure young children are thoroughly screened for eye disorders. Read More